Search results

Gender-based violence is a global pandemic existing in all social groups across the globe, yet it has largely been ignored in the COVID-19 response and recovery plans. Barriers to achieving gender justice continue to exist, but progress made since the start of the 16 Days of Activism Against Gender-Based Violence Campaign show that there are solutions.

Responding to the announcement that BioNTech plans to ship mobile vaccine factory containers to Africa, which could start producing vaccines in the second half of 2023, Oxfam’s Health Policy Manager, Anna Marriott, said:  “Efforts to boost vaccine manufacturing in Africa are welcome but this is a long-term project and should not distract from the failure of rich country governments and companies, including Germany and BioNTech, to tackle today’s shameful vaccine inequality responsible for millions of needless deaths in poorer countries from this pandemic.  

The Covid-19 vaccines are owned by big pharmaceutical corporations who are refusing to share the science and tech that could speed up affordable mass production and distribution for the entire planet. Join people from around the world to call for a #PeoplesVaccine, available to all, everywhere, free of charge.

Thirty-two of the world’s largest companies stand to see their profits jump by $109 billion more in 2020 as the Covid-19 pandemic lays bare an economic model that delivers profits for the wealthiest on the back of the poorest, according to a new Oxfam report today.

In response to reports of a potential compromise agreed by the EU, South Africa, India and the US for a waiver of intellectual property rules for COVID vaccines, Max Lawson, Head of Inequality Policy for Oxfam and co-chair of the People's Vaccine Alliance, said:   

In response to the statement issued today by the Organization for Economic Cooperation and Development’s (OECD) Development Assistance Committee, which says that countries will be able to count donations of unwanted vaccine doses as part of their foreign aid commitment, for a guideline cost of $6.72 a dose, Oxfam’s Health Policy Manager, Anna Marriott, said: “This guidance is a double insult to the world’s poorest countries. Firstly, rich countries bought up many more doses than they could use at a time of limited supply, preventing millions of people in developing countries from getting life-saving vaccines. Now they are free to charge any donations of unwanted doses to their aid budgets, to the detriment of other essential aid spending." 

Europe has betrayed Africa by blocking proposals which would allow manufacturers on the continent to make their own COVID-19 vaccines while hoarding millions of doses which are set to expire at the end of the month, warns the People’s Vaccine Alliance ahead of tomorrow’s meeting of African and European leaders at the AU-EU Summit. 

Syrians who have already endured almost a decade of war and displacement are now facing unprecedented levels of hunger leaving millions of people acutely vulnerable to Covid-19, international agencies warned today ahead of a key annual conference on the crisis.

Today, the European Commission presented a coronavirus crisis recovery package for the EU.

Today, EU member states have proposed a spending increase of 10 percent in 2019 for the EU’s external policies compared to this year’s budget. However, governments are focusing on the wrong issues, Oxfam, Save the Children, DSW and IPPF EN say. The organizations argue a strong focus on human development is needed to counter increasing inequalities and make sure no one is left behind.